Elimination of bacteremia caused by Mycoplasma haemofelis following dual therapy with doxycycline and ciprofloxacin

Document Type : Case report

Authors

1 Assistant Professor, Department of Internal Medicine and Clinical Pathology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran

2 Master of Science, Department of Internal Medicine and Clinical Pathology, Faculty of Veterinary Medicine, Urmia Uni-versity, Urmia, Iran

Abstract

Mycoplasma haemofelis is small wall-less bacteria with worldwide prevalence that infect erythrocytes and without effective treatment may cause death. The failure of most antibiotic therapy protocols to effective elimination of this potentially zoonotic agent highlights the necessity to determine an optimal treatment. A two-year-old domestic shorthair cat was referred to veterinary hospital of Urmia University with symptoms of lethargy, fever, jaundice and anemia. Clinical findings, the results of Giemsa stained blood smear and polymerase chain reaction on 16S rRNA confirmed the infection caused by M. haemofelis. Doxycycline (10 mg/kg PO q24h) was administered for 4 weeks. However, no clinical improvement was achieved and persistence of M. haemofelis infection was observed on cytology. After starting dual therapy with the addition of ciprofloxacin (20 mg/kg PO q24h) for two weeks, elimination of bacteremia was confirmed by cytological re-examination and negative result of polymerase chain reaction as the preferred diagnostic method. According to the authors' knowledge, this is the first report of bacteremia elimination caused by M. haemofelis using dual treatment with doxycycline and ciprofloxacin. It is suggested that this protocol be tried for more feline patients.

Keywords

References

1- Hicks CA, Willi B, Riond B, Novacco M, Meli ML, Stokes CR, et al. Protective immunity against infection with Mycoplasma haemofelis. Clin Vaccine Immunol. 2015; 22(1): 108–18.
2- Ameldev P, Tresamol PV. Molecular detection and therapeutic management of feline mycoplasmosis. Iosr-Javs. 2017; 10(2): 83-6.
3- Hawley J, Yaaran T, Maurice S, Lappin MR. Amplification of Mycoplasma haemofelis DNA by a PCR for point-of-care use. J Vet Diagn Investig. 2018; 30(1): 140-43.
4- Ghazisaeedi F, Atyabi N, Zahrai Salehi T, Gentilini F, Ashrafi Tamai I, Akbarein H, et al. A molecular study of hemotropic mycoplasmas (hemoplasmas) in cats in Iran. Vet Clin Pathol. 2014; 43(3): 381-86.
5- Sykes JE. Feline hemotropic mycoplasmas. Vet Clin Small Anim. 2010; 20(1): 62-9.
6- Novacco M, Sugiarto S, Willi B, Baumann J, Spiri A, Oestmann A, et al. Consecutive antibiotic treatment with doxycycline and marbofloxacin clears bacteremia in Mycoplasma haemofelis-infected cats. Vet Microbiol. 2018; 217: 112-20.
7- Tasker S, Hofmann-Lehmann R, Belák S, Frymus T, Addie D, Grazia Pennisi M, et al. Haemoplasmosis in Cats: European guidelines from the ABCD on prevention and management. J Feline Med Surg. 2018; 20(3): 256-61.
8- Willi B, Boretti FS, Baumgartner C, Tasker S, Wenger B, Cattori V, et al. Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland. J Clin Microbiol. 2006; 44(3): 961-69.
9- Greene CE, Calpin J. Antimicrobial Drug Formulary. In: Greene CE, editor. Infectious Diseases of the Dog and Cat. 4th ed. Elsevier Missouri. 2012, P: 1234-235.
10- Ishak AM, Dowers KL, Cavanaugh MT, Powell CC, Hawley JR, Radecki SV, et al. Marbofloxacin for the treatment of experimentally induced Mycoplasma haemofelis infection in cats. J Vet Intern Med. 2008. 22(2): 288-92.
11- Dowers KL, Tasker S, Radecki SV, Lappin MR. Use of pradofloxacin to treat experimentally induced Mycoplasma haemofelis infection in cats. Am J Vet Res. 2009; 70(1): 105-11.
12- Lappin M, Miller W, Sellins K. Effect of doxycycline or orbifloxacin administration on Bartonella spp and Hemoplasma assay results in naturally exposed cats. Int J Appl Res Vet M. 2012; 10(3): 225-33.
New Findings in Veterinary Microbiology
Volume 3, Issue 2
April 2021
Pages 97-103

Files

History

  • Receive Date: 11 July 2021
  • Revise Date: 16 September 2021
  • Accept Date: 04 October 2021

Share

How to cite

Statistics